-1-Antichymotrypsin interaction with Aβ (1-40) inhibits fibril formation but does not affect the peptide toxicity

Neuroscience Letters

Volumn 211, Issue 1, 1996, Pages 45-48

  Aksenova, Marina V ^a   Aksenov, Michael Y ^a   Butterfield, D Allan ^a   Carney, John M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Amyloid; Fibril formation; Neurotoxicity; 1 Antichymotrypsin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; PEPTIDE FRAGMENT; SERINE PROTEINASE INHIBITOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GLIA CELL; HIPPOCAMPUS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SENILE PLAQUE; ANIMAL; CYTOLOGY; METABOLISM; NEUROFIBRILLARY TANGLE; PATHOLOGY;

ALPHA 1-ANTICHYMOTRYPSIN; AMYLOID BETA-PROTEIN; ANIMALS; CELLS, CULTURED; HIPPOCAMPUS; NEUROFIBRILLARY TANGLES; PEPTIDE FRAGMENTS; RATS; SERINE PROTEINASE INHIBITORS;

EID: 0029661902     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12717-8     Document Type: Article

References (21)

1. [1] Abraham, C.R., Selkoe, D.J. and Potter, H., Immunochemical identification of serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease, Cell, 52 (1988) 487-501.
2. [2] Aksenov, M. Yu., Aksenova, M.V., Butterfield, D.A., Hensley, K., Vigo-Pelfrey, C. and Carney, J.M., Glutamine synthetase-induced enhancement of Aβ(1-40) neurotoxicity accompanied by abrogation of fibril formation and amyloid β-peptide fragmentation, J. Neurochem, 66 (1996) 2050-2056.
3. [3] Butterfield, D.A., Hensley, K., Harris, M., Mattson, M. and Carney, J.M., β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in an sequence-specific fashion: implications to Alzheimer's disease, Biochem. Biophys. Res. Commun., 200 (1994) 710-715.
4. [4] Castaño, E.M., Prelli, F., Wisniewski, T., Golabek, A., Kumar, R.A. and Frangione, B., Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E, Biochem. J., 306 (1995) 599-604.
5. [5] Eriksson, S., Janciauskiene, S. and Lannfelt, L., Alpha 1-antichymotrypsin regulates β-amyloid peptide fibril formation, Proc. Natl. Acad. Sci. USA, 92 (1995) 2313-2317.
6. [6] Fraser, P.E., Nguyen, J.T., McLachlan, D.R., Abraham, C.R. and Kirschner, D.R., α-Antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro, J. Neurochem., 61 (1993) 298-305.
7. [7] Ikura, K., Takahata, K. and Sasaki, R., Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer β/A4 amyloid protein by transglutaminase, FEBS Lett., 326 (1993) 109-111.
8. [8] Kobayashi, T., Abe, K., Saito, H. and Nishiyama, N., Effect of α-antichymotrypsin on the toxicity of β-amyloid fragment 25-40 in rat primary cultured neurons, Neurosci. Lett., 172 (1994) 147-150.
9. [9] Hensley, K., Carney, J.M., Mattson, M.P., Aksenova, M.V., Harris, M.E., Wu, J.F., Floyd, R.A. and Butterfield, D.A., A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 3270-3274.
10. [10] Lorenzo, A. and Yankner, B.A., β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red, Proc. Natl. Acad. Sci. USA, 91 (1994) 12243-12247.
11. [11] Ma, J., Yee, A., Brewer, H.B., Das, S. and Potter, H., Amyloid-associated proteins α-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments, Nature, 372 (1994) 92-94.
12. [12] Matsubara, E., Frangione, B. and Ghiso, J., Characterization of apolipoprotein J-Alzheimer Aβ interaction, J. Biol. Chem., 270 (1995) 7563-7567.
13. [13] McGeer, P.L., Klegeris, A., Walker, D.G., Yasuhara, O. and McGeer, E.G., Pathological proteins in senile plaques, Tohoku J. Exp. Med., 174 (1994) 269-277.
14. [14] Oda, T., Wals, P., Osterbung, H., Johnson, S., Pasinetti, G., Morgan, T., Rozovsky, I., Stine, W.B., Snyder, S., Holzman, T., Krafft, G. and Finch, C., Clusterin (apoJ) alters the aggregation of amyloid β-peptide (Aβ 1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress, Exp. Neurol., 136 (1995) 22-31.
15. [15] Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W., Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci., 13 (1993) 1676-1687.
16. [16] Roher, A.E., Palmer, K.C., Yurewicz, E.C., Ball, M.J. and Greenberg, B.D., Morphological and biochemical analyses of amyloid plague core proteins purified from Alzheimer disease tissue, J. Neurochem., 61 (1993) 1916-1926.
17. [17] Schultz, J., Schaller, J., McKinley, M., Bradt, B., Cooper, N., May, P. and Rogers, J., Enhanced cytotoxicity of amyloid β-peptide by a complement dependent mechanism, Neurosci. Lett., 175 (1994) 99-102.
18. [18] Shearman, M.S., Ragan, C.I. and Iversen, L.L., Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death, Proc. Natl. Acad. Sci. USA, 91 (1994) 1470-1474.
19. [19] Whitson, J.S., Mims, M.P., Strittmatter, W.J., Yamaki, T., Morrisett, J.D. and Appel, S.H., Attenuation of the neurotoxic effect of Aβ peptide by apolipoprotein E, Biochem. Biophys. Res. Commun., 199 (1994) 163-170.
20. [20] Wisniewski, T., Golabek, A., Matsubara, E., Ghiso, J. and Frangione, B., Apolipoprotein E: binding to soluble Alzheimer's β-amyloid, Biochem. Biophys. Res. Commun., 192 (1993) 359-365.
21. [21] Yankner, B.A., Commentary and perspective on studies of β amyloid neurotoxicity, Neurobiol. Aging, 13 (1992) 615-616.